Abstract
Introduction: Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening disease defined by idiopathic heart failure towards the end of pregnancy or up to six months after delivery. 6–12 months recovery rates are 47–72% in recent cohorts, but data on longer term prognosis are few. PPCM is often preceded by preeclampsia and the two conditions share pathophysiological mechanisms including disturbed levels of the antiangiogenic factor soluble Fms-like tyrosine kinase (sFlt-1) and placental growth factor (PlGF).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: European Journal of Obstetrics & Gynecology and Reproductive Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.